August 4, 2021 Comments Off on New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT Posted in: Uncategorized
Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent expiration for Boehringer Ingelhe…
August 3, 2021 Comments Off on New patent expiration for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF Posted in: Uncategorized
Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Gla…